On 2026-08-05, Rapport Therapeutics, Inc. (RAPP) announced earnings per share of $-1.19 for the fiscal quarter ending 2026-06-30, missing the average analyst estimate of $-0.93.
The next expected annoucement date for quarterly earnings is 2026-11-05, with an average estimated earnings per share of $-1.21 for the fiscal quarter ending 2026-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-08-05 | 2026-06-30 | $-0.93 | $-1.19 |
| 2026-05-07 | 2026-03-31 | $-0.56 | $-0.42 |
| 2026-03-10 | 2025-12-31 | $-0.65 | $-0.72 |
| 2025-11-06 | 2025-09-30 | $-0.77 | $-0.71 |
| 2025-08-07 | 2025-06-30 | $-0.87 | $-0.75 |
| 2025-05-08 | 2025-03-31 | $-0.77 | $-0.68 |
| 2025-03-11 | 2024-12-31 | $-0.62 | $-0.57 |
| 2024-11-07 | 2024-09-30 | $-0.57 | $-0.50 |
| 2024-08-08 | 2024-06-30 | $-0.68 | $-1.70 |
| 2024-06-03 | 2024-03-31 | -- | $-11.07 |